The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration
Abstract
Multiple myeloma (MM) remains incurable, with a median survival of 3 to 4 years. This study shows direct effects of vascular endothelial growth factor (VEGF) upon MM and plasma cell leukemia (PCL) cells. The results indicate that VEGF triggers tumor cell proliferation via a protein kinase C (PKC)–independent Raf-1–MEK–extracellular signal-regulated protein kinase pathway, and migration via a PKC-dependent pathway. These observations provide the framework for novel therapeutic strategies targeting VEGF signaling cascades in MM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Cell Migration: A Physically Integrated Molecular Process
Lauffenburger, D. A., & Horwitz, A. F. (1996) · Cell · doi:10.1016/s0092-8674(00)81280-5 · Cited by 3,915
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
Vascular endothelial growth factor (VEGF) and its receptors
NEUFELD, G., COHEN, T., GENGRINOVITCH, S., & POLTORAK, Z. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.9 · Cited by 3,483
A synthetic inhibitor of the mitogen-activated protein kinase cascade.
Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J., & Saltiel, A. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7686 · Cited by 2,679
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
Singhal, S., Mehta, J., Desikan, R., Ayers, D., Roberson, P., Eddlemon, P., Munshi, N., Anaissie, E., Wilson, C., Dhodapkar, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911183412102 · Cited by 2,575
Thalidomide is an inhibitor of angiogenesis.
D'Amato, R. J., Loughnan, M. S., Flynn, E., & Folkman, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4082 · Cited by 2,454
Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF
Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., & Connolly, D. T. (1989) · Science · doi:10.1126/science.2479987 · Cited by 2,061
The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor
de Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., & Williams, L. T. (1992) · Science · doi:10.1126/science.1312256 · Cited by 2,016
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
Holmgren, L., O'Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,878
Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., & Böhlen, P. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90483-2 · Cited by 1,519
Barleon, B., Sozzani, S., Zhou, D., Weich, H., Mantovani, A., & Marme, D. (1996) · Blood · doi:10.1182/blood.v87.8.3336.bloodjournal8783336 · Cited by 1,356
The implications of angiogenesis for the biology and therapy of cancer metastasis
Fidler, I. (1994) · Cell · doi:10.1016/0092-8674(94)90187-2 · Cited by 1,098
Rousseau, S., Houle, F., Landry, J., & Huot, J. (1997) · Oncogene · doi:10.1038/sj.onc.1201380 · Cited by 845
The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities
Clauss, M., Weich, H., Breier, G., Knies, U., Röckl, W., Waltenberger, J., & Risau, W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17629 · Cited by 836
Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process
Hallek, M., Leif Bergsagel, P., & Anderson, K. C. (1998) · Blood · doi:10.1182/blood.v91.1.3 · Cited by 752
Self-citationFukada, T., Hibi, M., Yamanaka, Y., Takahashi-Tezuka, M., Fujitani, Y., Yamaguchi, T., Nakajima, K., & Hirano, T. (1996) · Immunity · doi:10.1016/s1074-7613(00)80501-4 · Cited by 652
Bone marrow angiogenesis and progression in multiple myeloma
Vacca, A., Ribatti, D., Roncali, L., Ranieri, G., Serio, G., Silvestris, F., & Dammacco, F. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb08304.x · Cited by 630
Vacca, A., Ribatti, D., Presta, M., Minischetti, M., Iurlaro, M., Ria, R., Albini, A., Bussolino, F., & Dammacco, F. (1999) · Blood · doi:10.1182/blood.v93.9.3064 · Cited by 599
Dankbar, B., Padró, T., Leo, R., Feldmann, B., Kropff, M., Mesters, R. M., Serve, H., Berdel, W. E., & Kienast, J. (2000) · Blood · doi:10.1182/blood.v95.8.2630 · Cited by 566
Chauhan, D., Uchiyama, H., Akbarali, Y., Urashima, M., Yamamoto, K., Libermann, T., & Anderson, K. (1996) · Blood · doi:10.1182/blood.v87.3.1104.bloodjournal8731104 · Cited by 563
Self-citationOyama, T., Ran, S., Ishida, T., Nadaf, S., Kerr, L. D., Carbone, D. P., & Gabrilovich, D. I. (1998) · PubMed · Cited by 530
VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular Matrix
Poltorak, Z., Cohen, T., Sivan, R., Kandelis, Y., Spira, G., Vlodavsky, I., Keshet, E., & Neufeld, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.7151 · Cited by 519
Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies.
Bellamy, W. T., Richter, L., Frutiger, Y. M., & Grogan, T. M. (1999) · PubMed · Cited by 515
Keyt, B. A., Nguyen, H. V., Berleau, L. T., Duarte, C. M., Park, J., Chen, H., & Ferrara, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5638 · Cited by 497
Oyama, T., Ran, S., Ishida, T., Nadaf, S., Kerr, L., Carbone, D. P., & Gabrilovich, D. I. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1224 · Cited by 481
Fiedler, W., Graeven, U., Ergün, S., Verago, S., Kilic, N., Stockschläder, M., & Hossfeld, D. K. (1997) · Blood · doi:10.1182/blood.v89.6.1870 · Cited by 437
Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration
Dias, S., Hattori, K., Zhu, Z., Heissig, B., Choy, M., Lane, W., Wu, Y., Chadburn, A., Hyjek, E., Gill, M., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8978 · Cited by 434
(1996) · Nature Medicine · doi:10.1038/nm1196-1267 · Cited by 429
Uchiyama, H., Barut, B., Mohrbacher, A., Chauhan, D., & Anderson, K. (1993) · Blood · doi:10.1182/blood.v82.12.3712.3712 · Cited by 418
Self-citationIL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade
Ogata, A., Chauhan, D., Teoh, G., Treon, S. P., Urashima, M., Schlossman, R. L., & Anderson, K. C. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.5.2212 · Cited by 399
Self-citationNakagawa, M., Kaneda, T., Arakawa, T., Morita, S., Sato, T., Yomada, T., Hanada, K., Kumegawa, M., & Hakeda, Y. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01520-9 · Cited by 348
DiSalvo, J., Bayne, M. L., Conn, G., Kwok, P. W., Trivedi, P. G., Soderman, D. D., Palisi, T. M., Sullivan, K. A., & Thomas, K. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7717 · Cited by 297
Masood, R., Cai, J., Zheng, T., Smith, D. L., Naidu, Y., & Gill, P. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.3.979 · Cited by 279
Yaccoby, S., Barlogie, B., & Epstein, J. (1998) · Blood · doi:10.1182/blood.v92.8.2908 · Cited by 255
Ribatti, D., Vacca, A., Nico, B., Quondamatteo, F., Ria, R., Minischetti, M., Marzullo, A., Herken, R., Roncali, L., & Dammacco, F. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690070 · Cited by 247
Raje, N., & Anderson, K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911183412110 · Cited by 230
Self-citationStructure, Expression and Receptor-Binding Properties of Placenta Growth Factor (PlGF)
Persico, M. G., Vincenti, V., & DiPalma, T. (1999) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59953-8_2 · Cited by 195
Cornali, E., Zietz, C., Benelli, R., Weninger, W., Masiello, L., Breier, G., Tschachler, E., Albini, A., & Stürzl, M. (1996) · Europe PMC (PubMed Central) · Cited by 186
Samaniego, F., Markham, P. D., Gendelman, R., Watanabe, Y., Kao, V., Kowalski, K., SONNABEND, J. A., Pintus, A., Gallo, R. C., & Ensoli, B. (1998) · PubMed · Cited by 184
Shen, H., Clauss, M., Ryan, J., Schmidt, A., Tijburg, P., Borden, L., Connolly, D., Stern, D., & Kao, J. (1993) · Blood · doi:10.1182/blood.v81.10.2767.2767 · Cited by 177
Structure, Expression and Receptor-Binding Properties of Novel Vascular Endothelial Growth Factors
Eriksson, U., & Alitalo, K. (1999) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59953-8_3 · Cited by 165
Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants
Neufeld, G., Cohen, T., Gitay-Goren, H., Poltorak, Z., Tessler, S., Sharon, R., Gengrinovitch, S., & Levi, B.-Z. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00437467 · Cited by 165
The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases.
Sattler, M., Durstin, M., Frank, D. A., Okuda, K., Kaushansky, K., Salgia, R., & Griffin, J. D. (1995) · PubMed · Cited by 162
Self-citationAIDS-associated kaposi's sarcoma cells in culture express vascular endothelial growth factor
Weindel, K., Marmé, D., & Weich, H. A. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80313-4 · Cited by 161
IL-12 regulates VEGF and MMPs in a murine breast cancer model
Dias, S., Boyd, R., & Balkwill, F. R. (1998) · International Journal of Cancer · Cited by 137
The chemotactic response to PDGF-BB: evidence of a role for Ras.
Kundra, V., Anand‐Apte, B., Feig, L. A., & Zetter, B. R. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.130.3.725 · Cited by 115
Aoki, Y., & Tosato, G. (1999) · Blood · doi:10.1182/blood.v94.12.4247 · Cited by 113
Moalli, P., Pillay, S., Weiner, D., Goldman-Leikin, R. E., & Rosen, S. (1992) · Blood · doi:10.1182/blood.v79.1.213.bloodjournal791213 · Cited by 112
Vascular endothelial growth factor chimeric toxin is highly active against endothelial cells.
Arora, N., Masood, R., Zheng, T. Z., Cai, J., Smith, D. L., & Gill, P. S. (1999) · PubMed · Cited by 107
Whittle, C., Gillespie, K. M., Harrison, R., Mathieson, P. W., & Harper, S. J. (1999) · Clinical Science · doi:10.1042/cs0970303 · Cited by 88
Burchardt, M., Burchardt, T., Chen, M., Shabsigh, A., TAILLE, A. D. L., Buttyan, R., & Shabsigh, R. (1999) · Biology of Reproduction · doi:10.1095/biolreprod60.2.398 · Cited by 79
Kim, I. K., Uchiyama, H., Chauhan, D., & Anderson, K. C. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb08302.x · Cited by 70
Self-citationAntitumor Activity of Thalidomide in Refractory Multiple Myeloma
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420522 · Cited by 34
Sakurada, S., Kato, T., Mashiba, K., Mori, S., & Okamoto, T. (1996) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1996.tb03124.x · Cited by 10
Cited by
Tumor microenvironment and therapeutic response
Wu, T., & Dai, Y. (2017) · Cancer Letters · doi:10.1016/j.canlet.2016.01.043 · Cited by 1,802
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
Hideshima, T., Mitsiades, C., Tonon, G., Richardson, P. G., & Anderson, K. C. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2189 · Cited by 932
Self-citationDavies, F. E., Raje, N., Hideshima, T., Lentzsch, S., Young, G., Tai, Y.-T., Lin, B., Podar, K., Gupta, D., Chauhan, D., et al. (2001) · Blood · doi:10.1182/blood.v98.1.210 · Cited by 913
Self-citationRichardson, P. G., Schlossman, R. L., Weller, E., Hideshima, T., Mitsiades, C., Davies, F., LeBlanc, R., Catley, L. P., Doss, D., Kelly, K., et al. (2002) · Blood · doi:10.1182/blood-2002-03-0996 · Cited by 804
Self-citationAdvances in biology of multiple myeloma: clinical applications
Hideshima, T., Bergsagel, P. L., Kuehl, W. M., & Anderson, K. C. (2004) · Blood · doi:10.1182/blood-2004-01-0037 · Cited by 582
Self-citation
Metadata
- Authors
- Podar, K., Tai, Y.-T., Davies, F. E., Lentzsch, S., Sattler, M., Hideshima, T., Lin, B. K., Gupta, D., Shima, Y., Chauhan, D., Mitsiades, C., Raje, N., Richardson, P., & Anderson, K. C.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2001-07-15
- Volume
- 98
- Issue
- 2
- Pages
- 428-435
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2154374454
- Cited by
- 415
- References
- 59
- FWCI
- 18.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.